1Owen R T, Serradell N, Bolos J. AZD6140: antiplatelet therapy P2Y12(P2T) receptor antagonist [J]. Drug Fut, 2007, 32(10): 845-853.
2Springthorpe B, Bailey A, Barton P, et al. From ATP to AZD6140: The diseovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis[J]. Bioorg Med Chem Lett, 2007, 17(21): 6013-6018.
3Kowalczyk M, Banaeh M, Mikhailidis D P, et al. Tieagrelora new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors? [J]. Med Sei Monit, 2009, 15(12): MS24-MS30.
4Larsson U, Magnusson M, Musil T, et al. Novel triazole pyrimidine compounds: US, 2003148888A1 [P]. 2003-08-07.
6Storey R F. New developments in antiplatelet therapy [J]. Eur Heart J, 2008, 10(Suppl D): 30-37.
7Michelson A D. New P2Y12 antagonists [J]. Curr Opin Hematol, 2009, 16(5): 371-377.
8Cattaneo M. New P2Y12 blockers [J]. J Thromb Haemost, 2009, 7(Suppl 1): 262-265.
9Wallentin L, Becker R C, Budaj A, et al. Tieagrelor versus clopidogrel in patients with acute coronary syndromes[J]. N Engl J Med, 2009, 361(11): 1045-1057.
1LARSSON U, MAGNUSSON M, MUSIL T. Novel triazol- opyrimidine compounds: US,2 003 148 888 [ P]. 2003- 08-07.
2LARRON U, MAGNUSSON M,MUSIL T,ct al. Novel tri- azolo pyrimidine compounds : U S, 20 070 049 755 A 1 [ P 1. 2007-03-01.
3LARSSON U ,MATTIAS M ,TIBOR M ,et al. Novel triazo- lopyrimidine compounds : WO, 0 192 263A1 [ P ]. 2001- 12-06.
4NAIR V,TRIVEDI N, KHILE AS, et al. Novel process for preparing triazolo[ 4,5-d] pyrimidine derivatives and in- termediates thereof: WO, 2 012 085 665 [ P ]. 2003-06- 28.
5CREPALDI P, CACCIARI B. 6-Amino-2-mercapto-3H- pyrimidin-4-one derivatives as new candidates for the an- tagonism at the P2Y12 receptors [ J ]. Bioorg. Med. Chem. ,2009,17(13) :4 612-4 621.
6CREPALDI P, CACCIARI B. 6-Amino-2-mercapto-3H- pyrimidin-4-one derivatives as new candidates for the an- tagonism at the P2Y12 receptors [ J ]. Bioorg. Med. Chem. ,2009,17(13) :4 612-4 621.
8KHILE A S,PATEL J,TR1VEDI N. Improved processes for preparing ticagrelor intermediate,4,6-dichloro-5-ni- tro-2-(propylthio) pyrimidine : W 0,2 011 101 740 [ P ]. 2011-08-25.
